Dr. Liesbeth Ceelen is a leader with extensive experience in multinational environments as well as in start-up and scale-up companies. Over the last 15 years, she has gained expertise in operational and quality management, sales, scientific business development and strategic growth across the biotech and healthcare fields. As CEO of BioLizard, Liesbeth steers the BioLizard team, bringing both the scientific background and profound management skills to make BioLizard the go-to data science consultancy company across Europe and the US. Liesbeth leads by example, and her driving ambition is to inspire people and to help them grow. She does this not only within her role as CEO, but also through her involvement in Women on Board and the TOPX Network for Women in Life Sciences, and her mentorship via A Seat at the Table and Flanders.bio. Liesbeth’s work has been widely lauded: she was named named one of the Top 50 Inspiring Belgian Women in Tech in 2022 and one of the 10 Most Disruptive Women Leaders to Watch in 2023, alongside BioLizard being recognised as a finalist for the 2023 Healthtech company of the Year at the 2023 European Lifestars Awards. Alongside this, Liesbeth has recently finished an executive MBA programme at the Vlerick business school - embodying her focus on continuous learning and growth. Last but not least, Liesbeth is the proud mum of Lore, Elise and Lukas.

About BioLizard
BioLizard, located in Ghent, leverages its expertise in bioinformatics, biostatistics, machine learning, artificial intelligence and data mining to solve the most challenging questions in biology and deliver solutions to clients. By combining expertise from diverse backgrounds, BioLizard provides a complete solution to its client - from data analysis to the system integration and the development of an AI-aided interpretation system. The company was founded by Novalis Biotech Incubation. For more information visit the website.